skip to content

Broker Views

Broker Forecast - Morgan Stanley issues a broker note on Hikma Pharmaceuticals PLC

02 August 2017 09:10

Morgan Stanley today downgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to equal weight (from overweight) and cut its price target to 1600p (from 2050p).

Story provided by

Related Company: HIK

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?

Bluezest Aberdeen

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.